NCT06943053 Evaluation of Ioband Coverage Waterproof Dressing Versus Isolated Waterproof Dressing After Primary Total Knee Arthroplasty
| NCT ID | NCT06943053 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Thammasat University Hospital |
| Condition | Postoperative Wound Care After TKA |
| Study Type | INTERVENTIONAL |
| Enrollment | 96 participants |
| Start Date | 2025-04-06 |
| Primary Completion | 2026-04-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 96 participants in total. It began in 2025-04-06 with a primary completion date of 2026-04-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Title: Evaluation of Ioband® Coverage Waterproof Dressing in Post-Operative Total Knee Arthroplasty (TKA) Goal: To evaluate the effectiveness of Ioband® coverage waterproof dressing compared to standard waterproof dressing in reducing dressing change frequency and peel-off degree post-op TKA. Main Research Questions: 1. Does Ioband® coverage waterproof dressing significantly decrease the degree of peel-off compared to standard waterproof dressing? 2. Does Ioband® coverage reduce the number of wound dressing changes required post-operatively? 3. Does Ioband® coverage improve overall patient satisfaction compared to standard waterproof dressing? Participants: Participants will include patients who have undergone total knee arthroplasty (TKA). Main Tasks and Interventions: 1. Randomization: Participants will be randomly assigned to receive either the Ioband® coverage waterproof dressing or the standard waterproof dressing. 2. Application of Dressings: Participants will have the assigned dressing applied to their surgical site post-operatively. 3. Assessment of Peel-Off Degree: Participants will undergo assessments to evaluate the degree of peel-off of the dressing over a specified time. 4. Wound Dressing Changes: Participants will have their dressing changed as per routine care protocols, with documentation of the number of changes. 5. Patient Satisfaction Survey: Participants will complete a satisfaction survey to assess their experiences with the dressing and overall comfort. Conclusion: The trial aims to provide insights into the benefits of Ioband® coverage waterproof dressing in improving post-operative care for TKA patients, focusing on key outcomes related to dressing performance and patient satisfaction.
Eligibility Criteria
Inclusion Criteria: * Primary unilateral TKA * Age 55-80 yrs Exclusion Criteria: * Chronic Skin disease such as Psoriasis * Chronic steroid use * Allergy to skin adhesive, Cover wound * Robotic TKA * Iodine allergy * Not follow protocol
Contact & Investigator
Chanon Thassanaleelaporn, M.D.
PRINCIPAL INVESTIGATOR
Thammasat University Hospital Thailand
Frequently Asked Questions
Who can join the NCT06943053 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, studying Postoperative Wound Care After TKA. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06943053 currently recruiting?
Yes, NCT06943053 is actively recruiting participants. Contact the research team at krit.boontanapibul@gmail.com for enrollment information.
Where is the NCT06943053 trial being conducted?
This trial is being conducted at Pathum Thani, Thailand, Pathum Thani, Thailand.
Who is sponsoring the NCT06943053 clinical trial?
NCT06943053 is sponsored by Thammasat University Hospital. The principal investigator is Chanon Thassanaleelaporn, M.D. at Thammasat University Hospital Thailand. The trial plans to enroll 96 participants.